Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;24(4):325–329. doi: 10.1002/clc.4960240413

Collagen remodeling and cardiac dysfunction in patients with hypertrophic cardiomyopathy: The significance of type III and VI collagens

Masaru Kitamura 1, Masami Shimizu 1,, Hidekazu Ino 1, Kazuyasu Okeie 1, Masato Yamaguchi 1, Noboru Fujino 1, Hiroshi Mabuchi 1, Isao Nakanishi 2
PMCID: PMC6654813  PMID: 11303702

Abstract

Background: The relationship between the extent of myocardial interstitial fibrosis, the percentage of each type of collagen, and cardiac function in patients with hypertrophic cardiomyopathy (HC) has not been established.

Hypothesis: The study aimed to establish that increases in some types of collagen may correlate with cardiac dysfunction.

Methods: Mallory‐Azan staining and immunohistochemical staining by the avidin‐biotin‐complex (ABC) method using anticollagen antibodies were performed on the myocardial biopsy specimens in 35 patients with HC, and the percentage and type of collagen present was determined. Left ventricular (LV) function was evaluated by cardiac catheterization and ventriculography.

Results: The percentage of myocardial interstitial fibrosis correlated highly with indices of LV diastolic and systolic function. The amount of type III collagen correlated significantly with the peak negative dp/dt, the rapid filling volume/ stroke volume, and the ejection fraction (EF). Significant correlations also were noted between the amount of type VI collagen and peak negative dp/dt, peak positive dp/dt, and EF. Type I collagen did not correlate with any of the LV function indices, and type IV collagen correlated only with peak ejection rate. Type V collagen did not accumulate substantially in the myocardial interstitium.

Conclusions: The progression of myocardial interstitial fibrosis in the HC heart adversely impacts both the diastolic and systolic function of the LV. Increases in the percentage of type in and VI collagen correlate with cardiac dysfunction.

Keywords: hypertrophic cardiomyopathy, interstitial fibrosis, type III collagen, type IV collagen, cardiac dysfunction

Full Text

The Full Text of this article is available as a PDF (630.6 KB).

References

  • 1. Bonne G, Carrier L, Richard P, Hainque B, Schwartz K: Familial hypertrophic cardiomyopathy. From mutations to functional defects. Circ Res 1998; 83: 580–593 [DOI] [PubMed] [Google Scholar]
  • 2. Horita Y. Shimizu M. Sugihara N, Suematsu T, Shibayama S. Takeda R, Terada T: An autopsy case of hypertrophic cardiomyopathy showing dilated cardiomyopathy‐like features by serial ventriculography. Jpn J Med 1990; 29: 448–453 [DOI] [PubMed] [Google Scholar]
  • 3. Unverferth DV, Baker PB, Pearce LI, Lautman J, Roberts WC: Regional myocyte hypertrophy and increased interstitial myocardial fibrosis in hypertrophic cardiomyopathy. Am J Cardiol 1987: 59: 932–936 [DOI] [PubMed] [Google Scholar]
  • 4. Miller EJ: The structure of fibril‐forming collagens. Ann NY Acad Sci 1985; 460: 1–13 [DOI] [PubMed] [Google Scholar]
  • 5. Maron BJ, Epstein SE: Hypertrophic cardiomyopathy: A discussion of nomenclature. Am J Cardiol 1979; 43: 1242–1244 [DOI] [PubMed] [Google Scholar]
  • 6. Minamoto T. Ooi A, Okada Y, Mai M, Nagai Y, Nakanishi I: Desmoplastic reaction of gastric carcinoma: A light‐ and electron‐microscopic immunohistochemical analysis using collagen type specific antibodies. Hum Pathol 1988; 19: 815–821 [DOI] [PubMed] [Google Scholar]
  • 7. Kitamura M. Shimizu M, Kita Y, Yoshio H, Ino H, Misawa K, Matsuyama T, Mabuchi H: Quantitative evaluation of the myocardial interstitial fibrosis using a personal computer. Jpn Circ J 1997; 61: 781–786 [DOI] [PubMed] [Google Scholar]
  • 8. Shimizu M, Sugihara N, Kita Y, Shimizu K, Shibayama S, Takeda R: Increase in left ventricular chamber stiffness in patients with non‐insulin dependent diabetes mellitus. Jpn Circ J 1991; 55: 657–664 [DOI] [PubMed] [Google Scholar]
  • 9. Hirota Y, Furubayashi K, Kaku K, Shimizu G, Kino M, Kawamura K, Takatsu T: Hypertrophic non‐obstructive cardiomyopathy: A precise assessment of hemodynamic characteristic and clinical implications. Am J Cardiol 1982; 50: 990–997 [DOI] [PubMed] [Google Scholar]
  • 10. Pouleur H, Rousseau MF, van Eyll C, Brasseur LA, Charlier AA: Force‐velocity‐length relations in hypertrophic cardiomyopathy: Evidence of normal or depressed myocardial contractility. Am J Cardiol 1983; 52: 813–817 [DOI] [PubMed] [Google Scholar]
  • 11. McLain PE: Characterization of cardiac muscle collagen. J Biol Chem 1974; 249: 2303–2311 [PubMed] [Google Scholar]
  • 12. Borg TK, Gay RE, Johnson LD: Changes in the distribution of fi‐bronectin and collagen during developmental rat heart. Collagen Relat Res 1982; 2: 211–218 [DOI] [PubMed] [Google Scholar]
  • 13. Shimizu M, Umeda K, Sugihara N, Yoshio H, Ino H, Takeda R, Okada Y, Nakanishi I: Collagen remodeling in myocardia of patients with diabetes. J Clin Pathol 1993; 46: 32–36 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Weber KT, Pick R, Janicki JS, Gadodia G. Lakier JB: Inadequate collagen tethers in dilated cardiopathy. Am Heart J 1988; 116: 1641–1646 [DOI] [PubMed] [Google Scholar]
  • 15. Wever KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI: Collagen remodeling of the pressure‐overloaded, hypertrophied nonhuman primate myocardium. Circ Res 1988; 62: 757–765 [DOI] [PubMed] [Google Scholar]
  • 16. Engvall E, Hessel H, Klier G: Molecular assembly, secretion, and matrix deposition of type VI collagen. J Cell Biol 1986; 102: 703–710 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Spiro MJ, Clowley TG: Increased rat myocardial type VI collagen in diabetes mellitus and hypertension. Diabetologia 1993; 36: 93–98 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES